selected publications
-
Phase 1b trial of an ibrutinib-based combination therapy in recurrent/refractory CNS lymphoma.
Blood.
2018
Academic Article
GET IT
Times cited: 184 -
Correction regarding data on blinatumomab-associated seizures.
Nature reviews. Clinical oncology.
2016
Letter
GET IT
Times cited: 1 -
Cancer-treatment-induced neurotoxicity--focus on newer treatments.
Nature reviews. Clinical oncology.
2015
Review
GET IT
Times cited: 199 -
Diagnostic yield of echocardiography in cancer patients with ischemic stroke.
Journal of neuro-oncology.
2015
Academic Article
GET IT
Times cited: 25 -
Cryptogenic subtype predicts reduced survival among cancer patients with ischemic stroke.
Stroke.
2014
Academic Article
GET IT
Times cited: 76 -
Recurrent thromboembolic events after ischemic stroke in patients with cancer.
Neurology.
2014
Academic Article
GET IT
Times cited: 141 -
The type III TGF-β receptor betaglycan transmembrane-cytoplasmic domain fragment is stable after ectodomain cleavage and is a substrate of the intramembrane protease γ-secretase.
Biochimica et biophysica acta.
2010
Academic Article
GET IT
Times cited: 20